Solesence (NASDAQ:SLSN - Get Free Report) issued its earnings results on Thursday. The company reported $0.04 earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $20.36 million during the quarter. Solesence had a return on equity of 34.68% and a net margin of 8.13%.
Solesence Trading Down 19.0%
NASDAQ:SLSN traded down $0.65 during trading hours on Friday, hitting $2.78. The company had a trading volume of 110,471 shares, compared to its average volume of 72,832. The business's 50-day moving average price is $4.11. Solesence has a 1 year low of $1.21 and a 1 year high of $16.56. The firm has a market capitalization of $195.93 million, a P/E ratio of 39.71 and a beta of 0.87.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut Solesence from a "hold" rating to a "sell" rating in a report on Saturday, July 26th.
Read Our Latest Analysis on Solesence
Insider Transactions at Solesence
In other Solesence news, COO Kevin Cureton sold 38,807 shares of the company's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $3.80, for a total transaction of $147,466.60. Following the sale, the chief operating officer owned 192,212 shares in the company, valued at $730,405.60. This represents a 16.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 5.10% of the stock is owned by insiders.
About Solesence
(
Get Free Report)
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Solesence, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solesence wasn't on the list.
While Solesence currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.